Skip to content
Search
Generic filters
API Products
API Sourcing
Strategic Sourcing
505(b)(2) Pathway
Regulatory Support
Logistics
Manufacturer Management Program
CDMO Services
Formulation Development
Solid Dose Delivery Systems
Liquids / Suspensions
Semi-Solids
Suppositories
Commercial Scale-Up Facilities & Equipment
Regulatory Management
Analytical Services
Analytical Testing
Stability Services
Analytical Testing Services for Compounders
Analytical Testing for Manufacturers
Resources
About LGM
Quality Commitment
Leadership
Company History
Clients
News
Events
Careers
Blog
Contact Us
API Products
API Sourcing
Strategic Sourcing
505(b)(2) Pathway
Regulatory Support
Logistics
Manufacturer Management Program
CDMO Services
Formulation Development
Solid Dose Delivery Systems
Liquids / Suspensions
Semi-Solids
Suppositories
Commercial Scale-Up Facilities & Equipment
Regulatory Management
Analytical Services
Analytical Testing
Stability Services
Analytical Testing Services for Compounders
Analytical Testing for Manufacturers
Resources
About LGM
Quality Commitment
Leadership
Company History
Clients
News
Events
Careers
Blog
Contact Us
Resources
Knowledge Center for Partnering Smart
White Papers
High-Quality Analytical Testing for 503A Compounding Pharmacies
Formulating and Manufacturing Suppositories: A Guide for Niche Drug Developers
Outsourcing Analytical Testing: Three Problems to Avoid
Finding the Right CDMO for Your Niche Drug Project
Five “Must Ask” Questions to Find the Right CDMO
Five Reasons to Outsource API Procurement
Case Studies
For Startups, the Right CDMO partner Brings Expertise with a Personal Touch
How an ANDA Project Overcame Unique Sourcing and Manufacturing Challenges
Overcoming Unique ODT Manufacturing
Challenges to Improve Lives
Articles
2026
The Texas Pharmaceutical Landscape
From Predictions to Reality: Mike Stenberg Assesses Pharma Manufacturing’s First Half of 2026
LGM Pharma Expands U.S. CDMO Capacity and Navigates Reshoring, Supply-Chain Risks
Outsourcing Formulation Development & Manufacturing: Suppositories
The Realities of Pharmaceutical Onshoring: A CDMO Perspective
LGM Pharma Talks Texas, Colorado Investments at DCAT Week
LGM Pharma announces $9 million investment into Colorado and Texas manufacturing facilities
LGM Pharma Expands U.S. Manufacturing, Bringing Total Investment to $15M Across Texas and Colorado Sites
Navigating Financial Opportunity Risks in Accelerated Drug Launches
Pharmaceutical Supply Chain Resilience in a Shifting Market
2025
Mitigating Disruptions in API Supply: Building Resilient and Redundant Sourcing Strategies
Strategies for Successful Scale-Up of Suppository Drug Products
Drug Digest: Small Molecules, APIs, and Excipients—Trends, Challenges, and Opportunities
Navigating the Complexities of Orally Disintegrating Tablets
Emerging Tools, Integrated Controls Impact Tech Transfer
CDMOs: Key Leader Insights – Prasad Raje
Analytical Testing Outsourcing: Growth Trends & Outlook
What strategies are ensuring supply chain resilience in a post-COVID world?
OSD Manufacturing Market: Growth Trends & Outlook
LGM Pharma Invests $6M in U.S. Drug Manufacturing Capabilities for Liquids, Suspensions, Semi-Solids, and Suppositories
Biggest Threats to the CDMO Industry in 2026 and Beyond
Mosty Important New Technology Platforms in the CDMO Landscape
Renewed Interest and Investment in Small Molecules
GLP-1 Therapies Reshaping the Pharmaceutical Market
Building Supply Chain Resilience in a Shifting Market
GLP-1s, Digital Tech, and 505(b)(2) Strategies Reshaping the CDMO Landscape
2024
Dissecting Dissolution Testing
Diversifying the Supply of Raw Materials
2023
Trends in Formulation for Highly Potent Drugs
How Is Your Organization Currently Leveraging Real-World Data/Evidence and What Uses Do You Anticipate in the Future?
Data Integrity’s Impact in Drug Substance Testing
LGM Pharma Tech Outlook
2022
Meeting Demand for Semi-Solid Doses
CDMOs & Pharma: How are Supply Practices Changing?
Drug Solutions Podcast: The Evolving Landscape of Oral Solid Dosage Forms
The Role of CoAs in Supplier Oversight
2021
A Digital Supply Chain Helps Ensure API Quality
Balancing Pressing Priorities
Five Signs of an Effective CDMO Partnership
Packaging Considerations for Clinical Trial Materials
Building supply chain resiliency to ensure access to medicines
Securing Your API Supply Chain: Three Keys to Success
The future of outsourcing: What companies need to know
2020
A faster new product pathway
LGM Pharma Prasad Raje PhD CEO Acquisition of Nexgen Pharma
Ensuring a Safe and Robust Supply of Pharma Materials
Supply chain security in an insecure world: why drug developers are partnering with a new breed of API sourcing experts
Supply Chain Logistics Have Changed Are You Keeping Up?
Brochures
Drug Product CDMO Services
API Sourcing Services
Contract Analytical Testing Services
Videos
Public Service Announcements
Laryngopharyngeal Reflux (LPR) – a Common Misdiagnosis for GERD
How can we help?
Contact Us
